CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
ItalianoDERENZINI, ENRICO
Pubblicazioni
Risultati 1 - 20 di 64 (tempo di esecuzione: 0.001 secondi).
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
|---|---|---|---|---|---|---|---|
| 1 | A phase 2 trial of fludarabine and mitoxantrone chemoterapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma | Zinzani P.L.; Tani M.; Fanti S.; Stefoni V.; Musuraca G.; Vitolo U.; Perrotti A.; Fina M.; Derenz...ini E.; Baccarani M. | 2008 | CANCER | 1.01 Articolo in rivista | - | |
| 2 | A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma. | Brandi G; Biasco G; Mirarchi MG; Golfieri R; Di Paolo A; Borghi A; Fanello S; Derenzini E; Agosti...ni V; Giampalma E; Cappelli A; Pini P; Costantini S; Danesi R; Bolondi L; Piscaglia F | 2011 | DIGESTIVE AND LIVER DISEASE | 1.01 Articolo in rivista | - | |
| 3 | A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. | Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; P...ellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M. | 2012 | ANNALS OF ONCOLOGY | 1.01 Articolo in rivista | - | |
| 4 | Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. | Brandi G;Derenzini E;Falcone A;Masi G;Loupakis F;Pietrabissa A;Pinna AD;Ercolani G;Pantaleo MA;Di... Girolamo S;Grazi GL;de Rosa F;Biasco G | 2013 | CLINICAL COLORECTAL CANCER | 1.01 Articolo in rivista | - | |
| 5 | Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients | Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini ...F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL | 2013 | LEUKEMIA & LYMPHOMA | 1.01 Articolo in rivista | - | |
| 6 | An isolated penile mass in a young adult turned out to be a primary marginal zone lymphoma of the penis. A case report and a review of literature. | Gentile G;Broccoli A;Brunocilla E;Schiavina R;Borghesi M;Romagnoli D;Bianchi L;Derenzini E;Agosti...nelli C;Franceschelli A;Colombo F;Zinzani PL | 2013 | ANTICANCER RESEARCH | 1.01 Articolo in rivista | - | |
| 7 | Association of essential thrombocythemia and non-Hodgkin lymphoma: a single-centre experience | Palandri F; Derenzini E; Ottaviani E; Polverelli N; Catani L; Salmi F; Sabattini E; Bacci F; Zin...zani PL; Baccarani M; Vianelli N. | 2009 | LEUKEMIA & LYMPHOMA | 1.01 Articolo in rivista | - | |
| 8 | Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin. | Zinzani PL;Derenzini E;Pellegrini C;Celli M;Broccoli A;Argnani L | 2013 | BRITISH JOURNAL OF HAEMATOLOGY | 1.01 Articolo in rivista | - | |
| 9 | Bendamustine: role and evidence in lymphoma therapy, an overview. | E. Derenzini;P. L. Zinzani;B. D. Cheson | 2014 | LEUKEMIA & LYMPHOMA | 1.01 Articolo in rivista | - | |
| 10 | Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study | Zinzani P.L.;Pellegrini C.;Merla E.;Ballerini F.;Fabbri A.; Guarini A.;Pavone V.;Quintini G.;Pucc...ini B.;Vigliotti M.L.; Stefoni V.; Derenzini E.;Broccoli A.;Gandolfi L.;Quirini F.;Casadei B.;Argnani L.;Baccarani M. | 2013 | HEMATOLOGICAL ONCOLOGY | 1.01 Articolo in rivista | - | |
| 11 | Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials. | Zinzani PL;Viviani S;Anastasia A;Vitolo U;Luminari S;Zaja F;Corradini P;Spina M;Brusamolino E;Gia...nni AM;Santoro A;Botto B;Derenzini E;Pellegrini C;Argnani L | 2013 | HAEMATOLOGICA | 1.01 Articolo in rivista | ||
| 12 | Clinical safety and efficacy of adjuvant chemotherapy in radically resected cholangiocarcinoma patients. | Di Girolamo S; de Rosa F; Derenzini E; Frega G; Barbera AM; Ercolani G; Pinna AD; Biasco G; Brand...i G. | 2011 | I SUPPLEMENTI DI TUMORI | 4.03 Poster | - | |
| 13 | Collection of Hematopoietic Stem Cells after Previous Radioimmunotherapy is Feasible and Does Not Impair Engraftment after Autologous Stem Cell Transplantation in Follicular Lymphoma. | Derenzini E; Stefoni V; Maglie R; Casadei B; Pellegrini C; Broccoli A; Stefani G; Fanti S; Motta ...MR; Narducci R; Argnani L; Zinzani PL. | 2013 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 1.01 Articolo in rivista | - | |
| 14 | Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial. | Zinzani P.L.; Pellegrini C.; Gandolfi L.; Stefoni V.; Quirini F.; Derenzini E.; Broccoli A.; Argn...ani L.; Pileri S.; Baccarani M. | 2011 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 1.01 Articolo in rivista | - | |
| 15 | Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports. | Broccoli A;Derenzini E;Pellegrini C;Narducci R;Stefani G;Casadei B;Argnani L;Zinzani PL | 2013 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 1.01 Articolo in rivista | - | |
| 16 | Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma | Derenzini, Enrico; Agostinelli, Claudio; Imbrogno, Enrica; Iacobucci, Ilaria; Casadei, Beatrice; ...Brighenti, Elisa; Righi, Simona; Fuligni, Fabio; Ghelli Luserna Di Rorà, Andrea; Ferrari, Anna; Martinelli, Giovanni; Pileri, Stefano; Zinzani, Pier Luigi | 2015 | ONCOTARGET | 1.01 Articolo in rivista | - | |
| 17 | Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma. Leuk Lymphoma. | Derenzini E; Stefoni V; Pellegrini C; Fina MP; Broccoli A; Venturini F; Gandolfi L; Pileri SA; M...artelli M; Petti MC; Perrotti A; De Renzo A; Zaja F;Baccarani M; Zinzani PL. | 2009 | LEUKEMIA & LYMPHOMA | 1.01 Articolo in rivista | - | |
| 18 | Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue | Ciavarella, S; Vegliante, M C; Fabbri, M; De Summa, S; Melle, F; Motta, G; De Iuliis, V; Opinto, ...G; Enjuanes, A; Rega, S; Gulino, A; Agostinelli, C; Scattone, A; Tommasi, S; Mangia, A; Mele, F; Simone, G; Zito, A F; Ingravallo, G; Vitolo, U; Chiappella, A; Tarella, C; Gianni, A M; Rambaldi, A; Zinzani, P L; Casadei, B; Derenzini, E; Loseto, G; Pileri, A; Tabanelli, V; Fiori, S; Rivas-Delgado, A; López-Guillermo, A; Venesio, T; Sapino, A; Campo, E; Tripodo, C; Guarini, A; Pileri, S A | 2018 | ANNALS OF ONCOLOGY | 1.01 Articolo in rivista | ||
| 19 | Extramedullary myeloid tumour of the stomach and duodenum presenting without acute myeloblastic leukemia: a diagnostic and therapeutic challenge. | Derenzini E;Paolini S;Martinelli G;Campidelli C;Grazi GL;Calabrese C;Zinzani PL;Baccarani M. | 2008 | LEUKEMIA & LYMPHOMA | 1.01 Articolo in rivista | - | |
| 20 | Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens. | Zinzani PL; Pellegrini C; Gandolfi L; Casadei B; Derenzini E; Broccoli A; Quirini F; Argnani L; P...ileri S; Celli M; Fanti S; Poletti V; Stefoni V; Baccarani M. | 2013 | HEMATOLOGICAL ONCOLOGY | 1.01 Articolo in rivista | - |
Dettaglio
DERENZINI, ENRICO
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE
Copyright © 2020